1. Santesso N, Mustafa RA, Schunemann HJ, Arbyn M, Blumenthal PD, Cain J, et al. World health organization guidelines for treatment of cervical intraepithelial neoplasia 2-3 and screen‐and‐treat strategies to prevent cervical cancer. Int J Gynecol Obstet. 2016;132(3):252-8. [
Link] [
DOI:10.1016/j.ijgo.2015.07.038] [
PMID]
2. Canfell K, Kim JJ, Brisson M, Keane A, Simms KT, Caruana M, et al. Mortality impact of achieving WHO cervical cancer elimination targets: A comparative modelling analysis in 78 low-income and lower-middle-income countries. Lancet. 2020;395(10224):591-603. [
Link] [
DOI:10.1016/S0140-6736(20)30157-4]
3. World health organization. WHO guidelines for the use of thermal ablation for cervical pre-cancer lesions [Internet]. Geneva: World Health Organization; 2019 [cited 2021 Jan 1]. Available from: https://www.who.int/publications/i/item/9789241550598. [
Link]
4. Ghahramani M, Moodi M, Alami A, Moasheri N. Stages of pap smear screening change behavior based on TTM in women referring to health centers in Gonabad-years 1393. Mod Care J. 2015;11(4):304-15. [Persian] [
Link]
5. Alyaemni A, Teobald S, Faragher B, Jehan K, Tolhurst R. Gender inequities in health: An exploratory qualitative study of Saudi women's perceptions. Women Health. 2013;53(7):741-59. [
Link] [
DOI:10.1080/03630242.2013.829169] [
PMID]
6. Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136(5):E359-86. [
Link] [
DOI:10.1002/ijc.29210] [
PMID]
7. Aminisani N, Armstrong BK, Canfell K. Cervical cancer screening in Middle Eastern and Asian migrants to Australia: A record linkage study. Cancer Epidemiol. 2012;36(6):394-400. [
Link] [
DOI:10.1016/j.canep.2012.08.009] [
PMID]
8. Khodakarami N, Farah F, Yavari P, Khayamzadeh M, Taheripanah R, Esmaeil Akbari M. The new guideline for cervical cancer screening in low risk Iranian women. Iran J Obstet Gynecol Infertil. 2014;17(95):8-17. [Persian] [
Link]
9. Haghshenas M, Golini-Moghaddam T, Rafiei A, Emadian O, Sheykhpour A, Ashrafi GH. Prevalence and type distribution of high-risk human papillomavirus in patients with cervical cancer: A population-based study. Infect Agent Cancer. 2013;8(1):20. [
Link] [
DOI:10.1186/1750-9378-8-20] [
PMID] [
PMCID]
10. Zaboli R, Sanaeinasab H. The Challenges and Solutions for Action of Social Determinants of Health in Iran: A qualitative study. Iran J Health Educ Commun. 2014;2(1):5-16. [Persian] [
Link]
11. Homedes N, Ugalde A. Why neoliberal health reforms have failed in Latin America. Health Policy. 2005;71(1):83-96. [
Link] [
DOI:10.1016/j.healthpol.2004.01.011] [
PMID]
12. Exworthy M. Policy to tackle the social determinants of health: using conceptual models to understand the policy process. Health Policy Plan. 2008;23(5):318-27. [
Link] [
DOI:10.1093/heapol/czn022] [
PMID]
13. Raphael D. Escaping from the phantom zone: Social determinants of health, public health units and public policy in Canada. Health Promot Int. 2009;24(2):193-8. [
Link] [
DOI:10.1093/heapro/dap005] [
PMID]
14. Marmot M, Friel S, Bell R, Houweling TAJ, Taylor S. Closing the gap in a generation: Health equity through action on the social determinants of health. Lancet. 2008;372(9650):1661-9. [
Link] [
DOI:10.1016/S0140-6736(08)61690-6]
15. Dolatian M, Mirabzadeh A, Forozan AS, Sajjadi H, Alavi Majd H, Moafi F. Preterm delivery and psycho-social determinants of health based on World Health Organization model in Iran: A narrative review. Glob J Health Sci. 2013;5(1):52-64. [
Link] [
DOI:10.5539/gjhs.v5n1p52] [
PMID]
16. Dekker S. Focusing climate change policy on health in cities. Rev Environ Energy Econ. 2014, Sep. [
Link]
17. Anderko L. Achieving health equity on a global scale through a community‐based, public health framework for action. J Law Med Ethics. 2010;38(3):486-9. [
Link] [
DOI:10.1111/j.1748-720X.2010.00507.x] [
PMID]
18. Moher D, Shamseer L, Clarke M, Ghersi D, Liberati A, Petticrew M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev. 2015;4(1):1. [
Link] [
DOI:10.1186/2046-4053-4-1] [
PMID] [
PMCID]
19. Al-Naggar RA, Low W, Isa ZM. Knowledge and barriers towards cervical cancer screening among young women in Malaysia. Asian Pac J Cancer Prev. 2010;11(4):867-73. [
Link]
20. Williams-Brennan L, Gastaldo D, Cole DC, Paszat L. Social determinants of health associated with cervical cancer screening among women living in developing countries: A scoping review. Arch Gynecol Obstet. 2012;286(6):1487-505. [
Link] [
DOI:10.1007/s00404-012-2575-0] [
PMID]
21. Tsu VD, Levin CE. Making the case for cervical cancer prevention: What about equity. Reprod Health Matters. 2008;16(32):104-12. [
Link] [
DOI:10.1016/S0968-8080(08)32411-2]
22. Claeys P, Gonzalez C, Gonzalez M, Page H, Bello RE, Temmerman M. Determinants of cervical cancer screening in a poor area: Results of a population‐based survey in Rivas, Nicaragua. Trop Med Int Health. 2002;7(11):935-41. [
Link] [
DOI:10.1046/j.1365-3156.2002.00953.x] [
PMID]
23. Winkler J, Bingham A, Coffey P, Handwerker WP. Women's participation in a cervical cancer screening program in northern Peru. Health Educ Res. 2008;23(1):10-24. [
Link] [
DOI:10.1093/her/cyl156] [
PMID]
24. Drain PK, Holmes KK, Hughes JP, Koutsky LA. Determinants of cervical cancer rates in developing countries. Int J Cancer. 2002;100(2):199-205. [
Link] [
DOI:10.1002/ijc.10453] [
PMID]
25. Reyes-Ortiz CA, Velez LF, Camacho ME, Ottenbacher KJ, Markides KS. Health insurance and cervical cancer screening among older women in Latin American and Caribbean cities. Int J Epidemiol. 2008;37(4):870-8. [
Link] [
DOI:10.1093/ije/dyn096] [
PMID] [
PMCID]
26. Paz Soldan VA, Lee FH, Carcamo C, Holmes KK, Garnett GP, Garcia P. Who is getting pap smears in urban Peru. Int J Epidemiol. 2008;37(4):862-9. [
Link] [
DOI:10.1093/ije/dyn118] [
PMID] [
PMCID]
27. Manica ST, De Lordes Drachler M, Teixeira LB, Ferla AA, Gouveia HG, Anschau F, et al. Socioeconomic and regional inequalities of pap smear coverage. Rev Gaucha Enferm. 2016;37(1):52287. [
Link] [
DOI:10.1590/1983-1447.2016.01.52287] [
PMID]
28. Jafari Shobeiri M, Chapari Ilkhchi A. Role of demographic and socioeconomic factors in cervical cancer. Iran J Obstet Gynecol Infertil. 2011;13(6):22-31. [Persian] [
Link]
29. Von Wagner C, Good A, Whitaker KL, Wardle J. Psychosocial determinants of socioeconomic inequalities in cancer screening participation: A conceptual framework. Epidemiol Rev. 2011;33(1):135-47. [
Link] [
DOI:10.1093/epirev/mxq018] [
PMID]
30. Cuesta DIL, Gomez Gutierrez LF. Accessibility to healthcare services in the recent cervical cytology performed in an urban area in Colombia. Revista Espanola Salud Publica. 2004;78(3):367-77. [Spanish] [
Link] [
DOI:10.1590/S1135-57272004000300006] [
PMID]
31. Visanuyothin S, Chompikul J, Mongkolchati A. Determinants of cervical cancer screening adherence in urban areas of Nakhon Ratchasima province, Thailand. J Infect Public Health. 2015;8(6):543-52. [
Link] [
DOI:10.1016/j.jiph.2015.04.018] [
PMID]
32. Ansink A, Tlhurst R, Haque R, Saha S, Datta S, Van Den Broek NR. Cervical cancer in Bangladesh: Community perceptions of cervical cancer and cervical cancer screening. Trans R Soc Trop Med Hyg. 2008;102(5):499-505. [
Link] [
DOI:10.1016/j.trstmh.2008.01.022] [
PMID]
33. Sankaranarayanan R, Rajkumar R, Arrossi S, Theresa R, Esmy PO, Mahe C, et al. Determinants of participation of women in a cervical cancer visual screening trial in rural south India. Cancer Detect Prev. 2003;27(6):457-65. [
Link] [
DOI:10.1016/j.cdp.2003.09.006] [
PMID]
34. Greenwald S, Conover LF. An approach to establish behavioral determinants for predicting participation in cervical cancer screening of Haitian women. Fertil Steril. 2014;102(3):154. [
Link] [
DOI:10.1016/j.fertnstert.2014.07.530]
35. Petkeviciene J, Ivanauskiene R, Klumbiene J. Sociodemographic and lifestyle determinants of non-attendance for cervical cancer screening in Lithuania, 2006-2014. Public Health. 2018;156:79-86. [
Link] [
DOI:10.1016/j.puhe.2017.12.014] [
PMID]
36. Jeong SJ, Saroha E, Knight J, Roofe M, Jolly PE. Determinants of adequate follow-up of an abnormal Papanicolaou result among Jamaican women in Portland, Jamaica. Cancer Epidemiol. 2011;35(2):211-6. [
Link] [
DOI:10.1016/j.canep.2010.07.004] [
PMID] [
PMCID]
37. Idowu A, Olowookere SA, Fagbemi AT, Ogunlaja OA. Determinants of cervical cancer screening uptake among women in Ilorin, North Central Nigeria: A community-based study. J Cancer Epidemiol. 2016;2016:6469240. [
Link] [
DOI:10.1155/2016/6469240] [
PMID] [
PMCID]
38. Tiruneh FN, Chuang KY, Morton Ntenda PA, Chuang YC. Individual-level and community-level determinants of cervical cancer screening among Kenyan women: A multilevel analysis of a nationwide survey. BMC Womens Health. 2017;17(1):109. [
Link] [
DOI:10.1186/s12905-017-0469-9] [
PMID] [
PMCID]
39. Amin R, Kolahi AA, Jahanmehr N, Abadi AR, Sohrabi MR. Disparities in cervical cancer screening participation in Iran: A cross-sectional analysis of the 2016 nationwide STEPS survey. BMC Public Health. 2020;20:1594. [
Link] [
DOI:10.1186/s12889-020-09705-2] [
PMID] [
PMCID]
40. Harder E, Juul KE, Jensen SM, Thomsen LT, Frederikson K, Kjaer SK. Factors associated with non-participation in cervical cancer screening: A nationwide study of nearly half a million women in Denmark. Prev Med. 2018;111:94-100. [
Link] [
DOI:10.1016/j.ypmed.2018.02.035] [
PMID]
41. Singh GK. Area socioeconomic variations in US cancer incidence, mortality, stage, treatment, and survival, 1975-1999. New York: US Department of Health and Human Services, National Institutes of Health, National Cancer Institute; 2003. [
Link]
42. Ward E, Jemal A, Cokkinides V, Singh GK, Cardinez C, Ghafoor A, et al. Cancer disparities by race/ethnicity and socioeconomic status. CA: Cancer J Clin. 2004;54(2):78-93. [
Link] [
DOI:10.3322/canjclin.54.2.78] [
PMID]